Northwest Biotherapeutics, Inc. (NWBO) shares are up 2.58% to $7.55 in early trading. The move comes on a big volume too with the issue currently trading more than 466K shares, compared to the average volume of 474K shares. The surge follows a Forbes article that mentions the name positively, suggesting the stock will reach a 2015 share-price range of at least $9 – $10.
Northwest Biotherapeutics is a Bethesda, Maryland-based biotechnology company that develops immunotherapy products to treat cancers in the United States and internationally. Its stock has a median consensus analyst price target of $5.00, and a 52-week trading range of $3.79 to $10.64.
On valuation measures, Northwest Biotherapeutics, Inc. shares have t-12 price/sales ratio of 786.81. EPS is ($2.09).
Ticker is up 10.84% year-over-year and 37.57% year-to-date.